NeuroScientific Biopharmaceuticals has ventured into the stem cell therapy market with a $5.1 million purchase of unlisted Perth-based company Isopogen.

Neural stem cells (NSCs) in the mammalian brain decline rapidly with age, leading to impairment of hippocampal memory function in later life. However, the relationship between epigenetic remodeling ...

Neuroscience Progressive remote memory decline coincides with parvalbumin interneuron hyperexcitability and enhanced inhibition of cortical engram cells in a mouse model of Alzheimer’s disease ...

Bone marrow-derived mesenchymal stromal cells (BM-MSCs) were cultured in a biomaterial scaffold and differentiated for 21 days using a chondrogenic medium to produce cartilage-like in vitro models.